RITSUKO KOMAKI to Molecular Targeted Therapy
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Molecular Targeted Therapy.
Connection Strength
0.029
-
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 04; 15(4):504-535.
Score: 0.017
-
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res. 2012 Mar 15; 18(6):1641-54.
Score: 0.012